U.S. authorizes Sobi’s drug to treat COVID-19 in high-risk patients
Nov 10 (Reuters) - Sobi North America, a unit of Swedish Orphan Biovitrum AB , said on Thursday the U.S. Food and Drug Administration authorized its arthritis drug for treatment of high-risk hospitalized COVID-19 patients.The drug,…